Google’s Gradient Ventures tops up BenchSci's funding to $27.2 mln

BenchSci, a Toronto-based biomedical artificial intelligence (AI) technology company, has raised an undisclosed investment from Gradient Ventures, Google’s AI fund. The deal brings total funding to $27.2 million. BenchSci last year closed a Series A financing led by Inovia Capital and joined by Gradient, Golden Ventures, Afore Capital, Real Ventures and Radical Ventures. Founded in 2015, BenchSci develops technology that enables scientists to run more successful experiments to accelerate drug discovery. Its first product is an AI-assisted antibody selection platform. BenchSci will use the funds raised to expand its Toronto team and global sales force to meet demand from pharmaceutical companies.

CanadaNorth AmericaBriefs